Cargando…

Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department

Atrial fibrillation (AF) is a rhythm disorder observed mostly amongst adults. AF has been regarded as one of the most important medical problems because it leads to thromboembolism and paralysis risks. Although warfarin has been used in the past to cope with this health problem, new oral anticoagula...

Descripción completa

Detalles Bibliográficos
Autores principales: Akman, Canan, Kırılmaz, Bahadır, Balcı, Serdal, Aksit, Ercan, Yurtseven, Ersan, Duygu, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912972/
https://www.ncbi.nlm.nih.gov/pubmed/33654628
http://dx.doi.org/10.7759/cureus.12963
_version_ 1783656697932283904
author Akman, Canan
Kırılmaz, Bahadır
Balcı, Serdal
Aksit, Ercan
Yurtseven, Ersan
Duygu, Ali
author_facet Akman, Canan
Kırılmaz, Bahadır
Balcı, Serdal
Aksit, Ercan
Yurtseven, Ersan
Duygu, Ali
author_sort Akman, Canan
collection PubMed
description Atrial fibrillation (AF) is a rhythm disorder observed mostly amongst adults. AF has been regarded as one of the most important medical problems because it leads to thromboembolism and paralysis risks. Although warfarin has been used in the past to cope with this health problem, new oral anticoagulant medicines have replaced it in the last few years. The new oral anticoagulants, namely, dabigatran etexilate, rivaroxaban, and apixaban, are currently being used in daily clinical practice and treatment guidelines. Since AF patients are supposed to receive long-term oral anticoagulant therapy, it is extremely important to provide them with accurate information and appropriate training regarding the treatment to decrease oncoming complications. This is a prospective study involving 168 patients who were admitted to the emergency department with AF and who were using oral anticoagulants. Findings indicate a lack of awareness in the patients regarding the effects and side effects of the drugs they take despite having been informed by the prescribing physician. We believe that informed action by patients with regard to the oral anticoagulants and their side effects will have an impact on the reduction in hospitalization observed. It will also make a substantial contribution to the quality of life of AF patients and to their use of medical services.
format Online
Article
Text
id pubmed-7912972
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-79129722021-03-01 Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department Akman, Canan Kırılmaz, Bahadır Balcı, Serdal Aksit, Ercan Yurtseven, Ersan Duygu, Ali Cureus Cardiology Atrial fibrillation (AF) is a rhythm disorder observed mostly amongst adults. AF has been regarded as one of the most important medical problems because it leads to thromboembolism and paralysis risks. Although warfarin has been used in the past to cope with this health problem, new oral anticoagulant medicines have replaced it in the last few years. The new oral anticoagulants, namely, dabigatran etexilate, rivaroxaban, and apixaban, are currently being used in daily clinical practice and treatment guidelines. Since AF patients are supposed to receive long-term oral anticoagulant therapy, it is extremely important to provide them with accurate information and appropriate training regarding the treatment to decrease oncoming complications. This is a prospective study involving 168 patients who were admitted to the emergency department with AF and who were using oral anticoagulants. Findings indicate a lack of awareness in the patients regarding the effects and side effects of the drugs they take despite having been informed by the prescribing physician. We believe that informed action by patients with regard to the oral anticoagulants and their side effects will have an impact on the reduction in hospitalization observed. It will also make a substantial contribution to the quality of life of AF patients and to their use of medical services. Cureus 2021-01-28 /pmc/articles/PMC7912972/ /pubmed/33654628 http://dx.doi.org/10.7759/cureus.12963 Text en Copyright © 2021, Akman et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Akman, Canan
Kırılmaz, Bahadır
Balcı, Serdal
Aksit, Ercan
Yurtseven, Ersan
Duygu, Ali
Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department
title Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department
title_full Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department
title_fullStr Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department
title_full_unstemmed Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department
title_short Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department
title_sort assessment of awareness levels about anticoagulants in patients with atrial fibrillation presenting to emergency department
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912972/
https://www.ncbi.nlm.nih.gov/pubmed/33654628
http://dx.doi.org/10.7759/cureus.12963
work_keys_str_mv AT akmancanan assessmentofawarenesslevelsaboutanticoagulantsinpatientswithatrialfibrillationpresentingtoemergencydepartment
AT kırılmazbahadır assessmentofawarenesslevelsaboutanticoagulantsinpatientswithatrialfibrillationpresentingtoemergencydepartment
AT balcıserdal assessmentofawarenesslevelsaboutanticoagulantsinpatientswithatrialfibrillationpresentingtoemergencydepartment
AT aksitercan assessmentofawarenesslevelsaboutanticoagulantsinpatientswithatrialfibrillationpresentingtoemergencydepartment
AT yurtsevenersan assessmentofawarenesslevelsaboutanticoagulantsinpatientswithatrialfibrillationpresentingtoemergencydepartment
AT duyguali assessmentofawarenesslevelsaboutanticoagulantsinpatientswithatrialfibrillationpresentingtoemergencydepartment